Proto-Oncogene Proteins c-ets
"Proto-Oncogene Proteins c-ets" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A family of transcription factors that share a unique DNA-binding domain. The name derives from viral oncogene-derived protein oncogene protein v-ets of the AVIAN ERYTHROBLASTOSIS VIRUS.
Descriptor ID |
D050783
|
MeSH Number(s) |
D12.776.260.665 D12.776.624.664.700.175 D12.776.930.720
|
Concept/Terms |
Proto-Oncogene Proteins c-ets- Proto-Oncogene Proteins c-ets
- Proto Oncogene Proteins c ets
- c-ets, Proto-Oncogene Proteins
- Proto-Oncogene Protein ets
- Proto Oncogene Protein ets
- ets Transcription Factors
- Transcription Factors, ets
- c-ets Proto-Oncogene Proteins
- Proto-Oncogene Proteins, c-ets
- c ets Proto Oncogene Proteins
- ets Proto-Oncogene Proteins
- Proto-Oncogene Proteins, ets
- ets Proto Oncogene Proteins
- c-ets Protein
- c ets Protein
|
Below are MeSH descriptors whose meaning is more general than "Proto-Oncogene Proteins c-ets".
Below are MeSH descriptors whose meaning is more specific than "Proto-Oncogene Proteins c-ets".
This graph shows the total number of publications written about "Proto-Oncogene Proteins c-ets" by people in this website by year, and whether "Proto-Oncogene Proteins c-ets" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 0 | 3 | 3 |
1997 | 0 | 2 | 2 |
1998 | 0 | 1 | 1 |
2000 | 0 | 4 | 4 |
2002 | 0 | 2 | 2 |
2003 | 0 | 4 | 4 |
2004 | 1 | 5 | 6 |
2005 | 1 | 2 | 3 |
2006 | 1 | 0 | 1 |
2007 | 2 | 0 | 2 |
2008 | 3 | 0 | 3 |
2009 | 1 | 0 | 1 |
2010 | 1 | 0 | 1 |
2011 | 1 | 0 | 1 |
2012 | 0 | 1 | 1 |
2013 | 0 | 1 | 1 |
2014 | 0 | 1 | 1 |
2017 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Proto-Oncogene Proteins c-ets" by people in Profiles.
-
The ETS family of oncogenic transcription factors in solid tumours. Nat Rev Cancer. 2017 06; 17(6):337-351.
-
FLI1 expression is correlated with breast cancer cellular growth, migration, and invasion and altered gene expression. Neoplasia. 2014 Oct; 16(10):801-13.
-
Persistence of LPS-induced lung inflammation in surfactant protein-C-deficient mice. Am J Respir Cell Mol Biol. 2013 Nov; 49(5):845-54.
-
Setting Snail2's pace during EMT. Nat Cell Biol. 2012 Nov; 14(11):1122-3.
-
Mechanisms and functional consequences of PDEF protein expression loss during prostate cancer progression. Prostate. 2011 Dec; 71(16):1723-35.
-
Transcriptional regulation of p21/CIP1 cell cycle inhibitor by PDEF controls cell proliferation and mammary tumor progression. J Biol Chem. 2010 Apr 09; 285(15):11258-69.
-
PDEF is a negative regulator of colon cancer cell growth and migration. J Cell Biochem. 2009 Dec 15; 108(6):1389-98.
-
MicroRNA-mediated inhibition of prostate-derived Ets factor messenger RNA translation affects prostate-derived Ets factor regulatory networks in human breast cancer. Cancer Res. 2008 Oct 15; 68(20):8499-506.
-
Global gene expression analysis identifies PDEF transcriptional networks regulating cell migration during cancer progression. Mol Biol Cell. 2008 Sep; 19(9):3745-57.
-
ETS transcription factors: oncogenes and tumor suppressor genes as therapeutic targets for prostate cancer. Expert Rev Anticancer Ther. 2008 Jan; 8(1):33-42.